The role of aging upon β cell turnover

Journal of Clinical Investigation

Volumn 123, Issue 3, 2013, Pages 990-995

  Kushner, Jake A ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b TEXAS CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; EXENDIN 4; MITOGEN ACTIVATED PROTEIN KINASE P38; PLATELET DERIVED GROWTH FACTOR; PROTEIN P16; SOMATOMEDIN C;

ACINAR CELL; AGE; AGING; CELL CYCLE; CELL CYCLE PROGRESSION; CELL DIVISION; CELL FUNCTION; CELL PROLIFERATION; CELL REGENERATION; CELLULAR SECRETION; DIABETIC PATIENT; EPIGENETICS; GLUCOSE HOMEOSTASIS; HUMAN; INSULIN RELEASE; KNOCKOUT MOUSE; MITOGENICITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PANCREAS ISLET BETA CELL; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; TURNOVER TIME;

AGING; ANIMALS; CELL CYCLE; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DIABETES MELLITUS; EPIGENESIS, GENETIC; HUMANS; INSULIN; INSULIN-SECRETING CELLS; MITOSIS; PANCREAS; REGENERATION;

EID: 84874638291     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI64095     Document Type: Review

References (64)

1. Bluestone JA, Herold K, Eisenbarth G. Genetics, pathogenesis and clinical interventions in type 1 diabetes. Nature. 2010;464(7293):1293-1300.
2. Fink RI, Kolterman OG, Griffin J, Olefsky JM. Mechanisms of insulin resistance in aging. J Clin Invest. 1983;71(6):1523-1535. (Pubitemid 13056757)
3. Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature. 2006;444(7121):840-846. (Pubitemid 46024990)
4. Kahn SE, Zraika S, Utzschneider KM, Hull RL. The beta cell lesion in type 2 diabetes: there has to be a primary functional abnormality. Diabetologia. 2009; 52(6):1003-1012.
5. Kahn BB. Type 2 Diabetes: When insulin secretion fails to compensate for insulin resistance. Cell. 1998; 92(5):593-596. (Pubitemid 28141507)
6. Rhodes CJ. Type 2 diabetes-a matter of beta-cell life and death? Science. 2005;307(5708):380-384. (Pubitemid 40139973)
7. Dor Y, Brown J, Martinez OI, Melton DA. Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation. Nature. 2004; 429(6987):41-46. (Pubitemid 38620543)
8. Teta M, Rankin MM, Long SY, Stein GM, Kushner JA. Growth and regeneration of adult Beta cells does not involve specialized progenitors. Dev Cell. 2007;12(5):817-826. (Pubitemid 46667754)
9. Brennand K, Huangfu D, Melton D. All beta cells contribute equally to islet growth and maintenance. PLoS Biol. 2007;5(7):e163.
10. Carlotti F, Zaldumbide A, Ellenbroek JH, Spijker HS, Hoeben RC, de Koning EJ. beta-Cell generation: can rodent studies be translated to humans? J Transplant. 2011;2011:892453.
11. Madsen LW, et al. GLP-1 receptor agonists and the thyroid: C-cell effects in mice are mediated via the GLP-1 receptor and not associated with RET activation. Endocrinology. 2012;153(3):1538-1547.
12. Koopman RJ, Mainous AG 3rd, Diaz VA, Geesey ME. Changes in age at diagnosis of type 2 diabetes mellitus in the United States, 1988 to 2000. Ann Fam Med. 2005;3(1):60-63. (Pubitemid 40203949)
13. Paulson RJ, et al. Pregnancy in the sixth decade of life: obstetric outcomes in women of advanced reproductive age. JAMA. 2002;288(18):2320-2323. (Pubitemid 35291763)
14. Niclauss N, et al. Influence of donor age on islet isolation and transplantation outcome. Transplantation. 2011;91(3):360-366.
15. Iozzo P, Beck-Nielsen H, Laakso M, Smith U, Yki-Jarvinen H, Ferrannini E. Independent influence of age on basal insulin secretion in nondiabetic humans. European Group for the Study of Insulin Resistance. J Clin Endocrinol Metab. 1999;84(3):863-868. (Pubitemid 29138209)
16. Chang AM, Halter JB. Aging and insulin secretion. Am J Physiol Endocrinol Metab. 2003;284(1):E7-E12. (Pubitemid 36076216)
17. Basu R, et al. Mechanisms of the age-associated deterioration in glucose tolerance: contribution of alterations in insulin secretion, action, and clearance. Diabetes. 2003;52(7):1738-1748. (Pubitemid 36792465)
18. Utzschneider KM, et al. Impact of intra-abdominal fat and age on insulin sensitivity and beta-cell function. Diabetes. 2004;53(11):2867-2872. (Pubitemid 39425912)
19. Maedler K, et al. Aging correlates with decreased beta-cell proliferative capacity and enhanced sensitivity to apoptosis: a potential role for Fas and pancreatic duodenal homeobox-1. Diabetes. 2006; 55(9):2455-2462. (Pubitemid 44871145)
20. Finegood DT, Scaglia L, Bonner-Weir S. Dynamics of β-cell mass in the growing rat pancreas. Diabetes. 1995;44(3):249-256.
21. Teta M, Long SY, Wartschow LM, Rankin MM, Kushner JA. Very slow turnover of beta-cells in aged adult mice. Diabetes. 2005;54(9):2557-2567. (Pubitemid 41233576)
22. Stolovich-Rain M, Hija A, Grimsby J, Glaser B, Dor Y. Pancreatic Beta cells in very old mice retain capacity for compensatory proliferation. J Biol Chem. 2012;287(33):27407-27414.
23. Fan R, Kang Z, He L, Chan J, Xu G. Exendin-4 improves blood glucose control in both young and aging normal non-diabetic mice, possible contribution of beta cell independent effects. PLoS One. 2011;6(5):e20443.
24. Cnop M, et al. The long lifespan and low turnover of human islet beta cells estimated by mathematical modelling of lipofuscin accumulation. Diabetologia. 2010;53(2):321-330.
25. Cnop M, Igoillo-Esteve M, Hughes SJ, Walker JN, Cnop I, Clark A. Longevity of human islet alpha- and beta-cells. Diabetes Obes Metab. 2011; 13(suppl 1):39-46.
26. Perl S, et al. Significant human beta-cell turnover is limited to the first three decades of life as determined by in-vivo thymidine analog incorporation and radiocarbon dating. J Clin Endocrinol Metab. 2010;95(10):E234-E239.
27. Meier JJ, et al. Beta-cell replication is the primary mechanism subserving the postnatal expansion of beta-cell mass in humans. Diabetes. 2008; 57(6):1584-1594.
28. Saisho Y, Butler AE, Manesso E, Elashoff D, Rizza RA, Butler PC. beta-cell mass and turnover in humans: effects of obesity and aging. Diabetes Care. 2013;36(1):111-117.
29. Gregg BE, et al. Formation of a human beta-cell population within pancreatic islets is set early in life. J Clin Endocrinol Metab. 2012;97(9):3197-3206.
30. Sachdeva MM, Stoffers DA. Minireview: Meeting the demand for insulin: molecular mechanisms of adaptive postnatal beta-cell mass expansion. Mol Endocrinol. 2009;23(6):747-758.
31. Desgraz R, Bonal C, Herrera PL. beta-cell regeneration: the pancreatic intrinsic faculty. Trends Endocrinol Metab. 2011;22(1):34-43.
32. Granger A, Kushner JA. Cellular origins of beta-cell regeneration: a legacy view of historical controversies. J Intern Med. 2009;266(4):325-338.
33. Herrera PL, et al. Ablation of islet endocrine cells by targeted expression of hormone-promoterdriven toxigenes. Proc Natl Acad Sci U S A. 1994; 91(26):12999-13003.
34. Nir T, Melton DA, Dor Y. Recovery from diabetes in mice by beta cell regeneration. J Clin Invest. 2007;117(9):2553-2561. (Pubitemid 47494356)
35. Thorel F, et al. Conversion of adult pancreatic alpha-cells to beta-cells after extreme beta-cell loss. Nature. 2010;464(7292):1149-1154.
36. Kilborn SH, Trudel G, Uhthoff H. Review of growth plate closure compared with age at sexual maturity and lifespan in laboratory animals. Contemp Top Lab Anim Sci. 2002;41(5):21-26. (Pubitemid 135706624)
37. Horton JA, Bariteau JT, Loomis RM, Strauss JA, Damron TA. Ontogeny of skeletal maturation in the juvenile rat. Anat Rec (Hoboken). 2008; 291(3):283-292.
38. Rankin MM, Kushner JA. Adaptive beta-cell proliferation is severely restricted with advanced age. Diabetes. 2009;58(6):1365-1372.
39. Tschen SI, Dhawan S, Gurlo T, Bhushan A. Age-dependent decline in beta-cell proliferation restricts the capacity of beta-cell regeneration in mice. Diabetes. 2009;58(6):1312-1320.
40. Saisho Y, et al. Ongoing beta-cell turnover in adult nonhuman primates is not adaptively increased in streptozotocin-induced diabetes. Diabetes. 2011; 60(3):848-856.
41. Chen X, Zhang X, Chen F, Larson CS, Wang LJ, Kaufman DB. Comparative study of regenerative potential of beta cells from young and aged donor mice using a novel islet transplantation model. Transplantation. 2009;88(4):496-503.
42. Tian L, et al. Comparison of exendin-4 on betacell replication in mouse and human islet grafts. Transpl Int. 2011;24(8):856-864.
43. Wong ES, et al. p38MAPK controls expression of multiple cell cycle inhibitors and islet proliferation with advancing age. Dev Cell. 2009;17(1):142-149.
44. Vasavada RC, Gonzalez-Pertusa JA, Fujinaka Y, Fiaschi-Taesch N, Cozar-Castellano I, Garcia-Ocana A. Growth factors and beta cell replication. Int J Biochem Cell Biol. 2006;38(5-6):931-950. (Pubitemid 43363423)
45. Gunasekaran U, Gannon M. Type 2 diabetes and the aging pancreatic beta cell. Aging (Albany NY). 2011;3(6):565-575.
46. Kulkarni RN, Mizrachi EB, Ocana AG, Stewart AF. Human beta-cell proliferation and intracellular signaling: driving in the dark without a road map. Diabetes. 2012;61(9):2205-2213.
47. Krishnamurthy J, et al. Ink4a/Arf expression is a biomarker of aging. J Clin Invest. 2004; 114(9):1299-1307. (Pubitemid 40385301)
48. Krishnamurthy J, et al. p16INK4a induces an age-dependent decline in islet regenerative potential. Nature. 2006;443(7110):453-457. (Pubitemid 44477281)
49. Janzen V, et al. Stem-cell ageing modified by the cyclin-dependent kinase inhibitor p16INK4a. Nature. 2006;443(7110):421-426. (Pubitemid 44477274)
50. Molofsky AV, et al. Increasing p16INK4a expression decreases forebrain progenitors and neurogenesis during ageing. Nature. 2006;443(7110):448-452. (Pubitemid 44477280)
51. Saxena R, et al. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science. 2007;316(5829):1331-1336. (Pubitemid 46871653)
52. Scott LJ, et al. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science. 2007;316(5829):1341- 1345. (Pubitemid 46871655)
53. Zeggini E, et al. Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science. 2007;316(5829):1336- 1341. (Pubitemid 46871654)
54. Pascoe J, et al. Free fatty acids block glucose-induced beta-cell proliferation in mice by inducing cell cycle inhibitors p16 and p18. Diabetes. 2012; 61(3):632-641.
55. Dhawan S, Tschen SI, Bhushan A. Bmi-1 regulates the Ink4a/Arf locus to control pancreatic beta-cell proliferation. Genes Dev. 2009;23(8):906-911.
56. Chen H, et al. Polycomb protein Ezh2 regulates pancreatic beta-cell Ink4a/Arf expression and regeneration in diabetes mellitus. Genes Dev. 2009; 23(8):975-985.
57. Gilbert ER, Liu D. Epigenetics: The missing link to understanding beta-cell dysfunction in the pathogenesis of type 2 diabetes. Epigenetics. 2012; 7(8):841-852.
58. Chen H, et al. PDGF signalling controls age-dependent proliferation in pancreatic beta-cells. Nature. 2011;478(7369):349-355.
59. Swenne I. Effects of aging on the regenerative capacity of the pancreatic B-cell of the rat. Diabetes. 1983;32(1):14-19. (Pubitemid 13203691)
60. Salpeter SJ, Klein AM, Huangfu D, Grimsby J, Dor Y. Glucose and aging control the quiescence period that follows pancreatic beta cell replication. Development. 2010;137(19):3205-3213.
61. Sharpless NE, DePinho RA. How stem cells age and why this makes us grow old. Nat Rev Mol Cell Biol. 2007;8(9):703-713. (Pubitemid 47312828)
62. Conboy IM, Conboy MJ, Wagers AJ, Girma ER, Weissman IL, Rando TA. Rejuvenation of aged progenitor cells by exposure to a young systemic environment. Nature. 2005;433(7027):760-764. (Pubitemid 40292986)
63. Nilsson O, Marino R, De Luca F, Phillip M, Baron J. Endocrine regulation of the growth plate. Horm Res. 2005;64(4):157-165. (Pubitemid 41642759)
64. Balazik MT, Garman GC, Fine ML, Hager CH, McIninch SP. Changes in age composition and growth characteristics of Atlantic sturgeon (Acipenser oxyrinchus oxyrinchus) over 400 years. Biol Lett. 2010;6(5):708-710.